Since TIM-3 is highly expressed on CD8+ T and FoxP3 Treg cells, both of which assume key roles in the formation of tumor immunosuppression, blocking the TIM-3/galectin-9 pathway is of great interest [134]. The gene discussed is CD8A; the disease is neoplasm.